X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (40) 40
obstetrics & gynecology (26) 26
breast cancer (24) 24
medizin (18) 18
chemotherapy (15) 15
further section · weitere sektionen (14) 14
humans (13) 13
female (12) 12
index medicus (11) 11
cancer (10) 10
medicine & public health (10) 10
further section (9) 9
internal medicine (9) 9
therapy (8) 8
trastuzumab (8) 8
breast neoplasms - drug therapy (7) 7
breast neoplasms - pathology (7) 7
endocrine therapy (7) 7
hematology, oncology and palliative medicine (7) 7
middle aged (7) 7
research (7) 7
review article · übersichtsarbeit (7) 7
treatment outcome (7) 7
adult (6) 6
consensus (6) 6
tamoxifen (6) 6
trial (6) 6
aged (5) 5
breast neoplasms - mortality (5) 5
care and treatment (5) 5
chemotherapy, adjuvant (5) 5
combination (5) 5
disease-free survival (5) 5
early breast cancer (5) 5
metastasis (5) 5
metastatic breast cancer (5) 5
oncology, experimental (5) 5
prognosis (5) 5
survival (5) 5
targeted therapy (5) 5
adjuvant chemotherapy (4) 4
anthracyclines (4) 4
drug therapy (4) 4
education (4) 4
expression (4) 4
general practice / family medicine (4) 4
medical colleges (4) 4
neoplasm staging (4) 4
paclitaxel (4) 4
radiotherapy (4) 4
skin and connective tissue diseases (4) 4
women (4) 4
1st-line treatment (3) 3
adjuvant therapy (3) 3
adjuvant treatment (3) 3
analysis (3) 3
antineoplastic agents (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
axillary dissection (3) 3
biological markers (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - surgery (3) 3
breast neoplasms - therapy (3) 3
cancer therapies (3) 3
clinical information · klinische information (3) 3
docetaxel (3) 3
guidelines (3) 3
health aspects (3) 3
hematology (3) 3
kaplan-meier estimate (3) 3
neoplasm metastasis (3) 3
ovarian cancer (3) 3
postmenopausal women (3) 3
prospective studies (3) 3
randomized-trial (3) 3
receptor (3) 3
recurrence (3) 3
risk assessment (3) 3
risk factors (3) 3
surgery (3) 3
adjuvant endocrine therapy (2) 2
advanced breast cancer (2) 2
advanced breast-cancer (2) 2
age (2) 2
ago (2) 2
anthracycline (2) 2
antimitotic agents (2) 2
aromatase inhibitors (2) 2
biopsy (2) 2
bisphosphonates (2) 2
breast cancer, metastatic (2) 2
breast neoplasms - blood (2) 2
breast neoplasms - complications (2) 2
breast-cancer (2) 2
capecitabine (2) 2
cell death (2) 2
clinical trials as topic (2) 2
clinical-practice (2) 2
combined modality therapy (2) 2
cyclophosphamide (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016
Summary Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. Therapy has progressed... 
Internal Medicine
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9555, pp. 29 - 36
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 887 - 896
Summary Background Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | PROGNOSIS | PRETERM BIRTH | OUTCOMES | TAXANES | MODEL | ANTHRACYCLINES | CHEMOTHERAPY | CHILDREN | FEATURES | AGE | Breast Neoplasms - surgery | Multivariate Analysis | Carcinoma, Lobular - pathology | Infant, Newborn, Diseases - epidemiology | Birth Weight - drug effects | Carcinoma, Ductal - pathology | Humans | Middle Aged | Organ Preservation | Male | Infant, Newborn, Diseases - chemically induced | Carcinoma, Ductal - drug therapy | Pregnancy Outcome - epidemiology | Incidence | Young Adult | Apgar Score | Pregnancy Complications, Neoplastic - drug therapy | Adult | Female | Registries | Retrospective Studies | Infant, Newborn | Carcinoma, Lobular - secondary | Carcinoma, Lobular - surgery | Abnormalities, Drug-Induced - epidemiology | Europe | Lymphatic Metastasis | Carcinoma, Lobular - diagnosis | Breast Neoplasms - drug therapy | Pregnancy | Disease-Free Survival | Carcinoma, Ductal - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Carcinoma, Ductal - diagnosis | Breast Neoplasms - diagnosis | Carcinoma, Lobular - drug therapy | Delivery, Obstetric - statistics & numerical data | Neoplasm Staging | Cohort Studies | Care and treatment | Surgery, Plastic | Surgical clinics | Pregnant women | Oncology, Experimental | Breast cancer | Research | Drug therapy | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 357 - 366
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/S0140-6736(16)31891-8... 
Medical colleges | Adjuvant treatment | Breast cancer | Metastasis | Health aspects | Cancer
Journal Article
best practice onkologie, ISSN 0946-4565, 2/2018, Volume 13, Issue 1, pp. 24 - 30
Journal Article
MMW - Fortschritte der Medizin, ISSN 1438-3276, 8/2019, Volume 161, Issue 14, pp. 42 - 42
Journal Article
Breast Care, ISSN 1661-3791, 06/2007, Volume 2, Issue 3, pp. 130 - 134
The focus of this year’s St. Gallen Consensus Conference was on providing substantial and largely evidence-based recommendations for the treatment of early... 
Review Article · Übersichtsarbeit | Chemotherapy Antibody therapy | Breast cancer | Targeted therapy | Endocrine treatment | ADJUVANT CHEMOTHERAPY | endocrine treatment | targeted therapy | METAANALYSIS | TRASTUZUMAB | TAMOXIFEN | breast cancer | chemotherapy | ANASTROZOLE | OBSTETRICS & GYNECOLOGY | TRIAL | THERAPY | ONCOLOGY | POSTMENOPAUSAL WOMEN | antibody therapy
Journal Article
Breast Care, ISSN 1661-3791, 09/2008, Volume 3, Issue 4, pp. 279 - 282
Journal Article
Breast Care, ISSN 1661-3791, 05/2013, Volume 8, Issue 2, pp. 102 - 109
The 2013 St. Gallen Consensus Conference on early breast cancer provided mostly evidence-based, globally valid treatment recommendations for breast cancer... 
Review Article · Übersichtsarbeit | Neoadjuvant therapy | Axillary dissection | Chemotherapy | Targeted therapy | Surgery | Endocrine therapy | Early breast cancer | Bisphosphonates | INTERNATIONAL EXPERT CONSENSUS | PRIMARY THERAPY | HIGHLIGHTS | OBSTETRICS & GYNECOLOGY | BREAST-CANCER | ONCOLOGY | Review • Übersichtsarbeit
Journal Article
Breast Care, ISSN 1661-3791, 04/2015, Volume 10, Issue 2, pp. 124 - 130
The 2015 St. Gallen Consensus Conference on early breast cancer took place in Vienna, Austria, for the first time. After 3 days of high-level presentations by... 
Review Article | Neoadjuvant therapy | Axillary dissection | Chemotherapy | Targeted therapy | Surgery | Endocrine therapy | Early breast cancer | Radiotherapy | Bisphosphonates | OVARIAN SUPPRESSION | DIAGNOSIS | OBSTETRICS & GYNECOLOGY | TRIAL | THERAPY | ONCOLOGY | EARLY BREAST-CANCER | LONG | Review
Journal Article
Breast Care, ISSN 1661-3791, 08/2006, Volume 1, Issue 4, pp. 238 - 241
Adjuvant systemic chemotherapy reduces the risk of relapse by about 25%. In hormone receptor-negative tumors, adjuvant chemotherapy is considered standard,... 
Review Article · Übersichtsarbeit | AGO | Anthracyclines | Breast cancer, early | Taxanes | Chemotherapy, adjuvant | chemotherapy, adjuvant | CYCLOPHOSPHAMIDE | taxanes | METHOTREXATE | RANDOMIZED-TRIAL | FLUOROURACIL | PACLITAXEL | OBSTETRICS & GYNECOLOGY | PHASE-III TRIAL | THERAPY | EPIRUBICIN | ONCOLOGY | DOSE-DENSE | anthracyclines | breast cancer, early
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 2/2018, Volume 144, Issue 2, pp. 249 - 256
The Fas-antigen is a cell surface receptor that transduces apoptotic signals into cells. The purpose of this study was to evaluate FasL expression in breast... 
Fas ligand | Medicine & Public Health | Hematology | FasL reverse signaling | Oncology | Cancer Research | Internal Medicine | Breast cancer | Apoptosis | CORTICOTROPIN-RELEASING HORMONE | CD95 LIGAND | RECEPTOR | TRANSDUCTION | DEATH | PROLIFERATION | ONCOLOGY | CIRCULATING SOLUBLE FAS | TUMOR-GROWTH | EXPRESSION | LYMPHOCYTES | Interferon | Biological response modifiers | Analysis
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2018, Volume 168, Issue 3, pp. 631 - 638
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 03/2004, Volume 91, Issue 3, pp. 450 - 456
Urokinase-type plasminogen activator (uPA) and its inhibitor, PAI-1, play a key role in tumor invasion and metastasis. They were the first novel tumor... 
Theme Issue Review Article | Prognosis | Prediction of therapy response | Risk group assessment | Node-negative breast cancer | uPA | PAI-1 | Metastasis | Adjuvant therapy
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 47, Issue 15, pp. 2273 - 2281
Journal Article